Entering a ‘wheat pan-genomics’ era from single to multiple wheat DNA references, Bayer and the Earlham Institute (EI) aim to diversify one of the world’s most complex genomes to improve yield quality and increase wider production of this critical food crop.

• Board of Management member Dr. Klusik: “Efficient use of resources has been a cornerstone of our sustainability strategy for a number of years”

• Institutional investors rely on CDP rating

Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming / USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion / Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years / Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percentage accretion in the third full year / Committed to retaining strong presence in the U.S. with the combined business’ global Seeds & Traits and North American commercial headquarters in St. Louis